JBIO Aerovate: Forvard P/S multiplikatori

Aerovate (JBIO) korporativ emblemasi va logotipi

Aerovate Therapeutics Inc (JBIO) hozirda faol pul oqimlarisiz klinik sinovlar bosqichida bo'lib, o'zining qolgan likvidligiga tayanmoqda. Kompaniya o'pka arterial gipertenziyasiga qarshi kurashish uchun patentlangan molekulalarni ishlab chiqishga e'tibor qaratadi. GURU.Markets grafigida ko'rsatilganidek, forward P/S ko'rsatkichi baholash dinamikasini aks ettiradi, bunda parametrning joriy holatini belgilaydi. Klinikalar bilan strategik ittifoqlar sinergiya yaratib, startapning investitsiyaviy jozibadorligini oshiradi.

Aerovate Therapeutics, Inc. - JBIO Bozor kapitallashuvining kelajakdagi daromadga nisbati (davr: 04.07.2022 - 18.11.2026)

JBIO (Aerovate): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:Aerovate Therapeutics Inc JBIO
Aerovate Therapeutics, Inc. original mahsuloti

Aerovate Therapeutics Inc (JBIO) istiqbollari uning o'pka gipertoniyasi terapiyasining klinik samaradorligiga va sinovlarni yakunlash uchun kapitalning yetarliligiga bog'liq. Ushbu ko'rsatkich Aerovate Therapeutics Inc (JBIO) joriy bozor qiymatini kutilayotgan kelajakdagi savdo hajmlari bilan solishtiradi, bu esa investorlarga uzoq muddatli fundamental tendentsiyani qisqa muddatli bozor shovqinlaridan ajratuvchi forward daromad multiplikatori orqali narxga kiritilgan optimizm darajasini baholash imkonini beradi.

Aerovate Therapeutics Inc raqobatchilari

Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (Intrexon)|Forvard narx/daromad multiplikatori PHAR (Pharming)|NKTR (Nektar) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Kelajakdagi narxning daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Gossamer Bio Inc GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna Pharma|PVLA (Pieris Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati SVRA|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori AnaptysBio Corp ANAB|Astria Therapeutics Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Forvard P/S multiplikatori|ACRS - Forvard P/S multiplikatori|KYTX (Kyverna Therapeutics) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Tiziana Life Sciences Ltd. (TLSA)|Forvard narx/daromad multiplikatori CABA|Ventyx Biosciences (VTYX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (eledon.com)|AGEN - Forvard narx/daromad multiplikatori|CLYM - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati ZURA|ATYR: Forvard P/S multiplikatori|Adagene Corp (ADAG) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori IMA|Shattuck Labs, Inc. - Kelajakdagi narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Equillium Inc (EQ)|Forvard P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning prognoz qilingan daromadga nisbati Immunic, Inc. IMUX|Forvard P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning prognoz qilingan daromadga nisbati|XFOR: Narxning prognoz qilingan daromadga nisbati|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati inmunebio.com|Kapitalizatsiyaning prognoz qilingan daromadga nisbati BRNS (barinthusbio.com)|Forvard P/S multiplikatori KZR|Forvard P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|Forvard P/S multiplikatori AKTX (Akari Therapeutics, Plc)|Forvard P/S multiplikatori enlivex.com ENLV|QTTB: Forvard narx/daromad multiplikatori|GOVX - Forvard P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning prognoz qilingan daromadga nisbati|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati carismatx.com|XTLB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati aptevotherapeutics.com APVO|AIM - Forvard narx/daromad multiplikatori|Aditxt - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati reshapelifesciences.com (HIND)|Narxning prognoz qilingan daromadga nisbati Revelation Bio|Bozor kapitallashuvining kelajakdagi daromadga nisbati Indaptus Therapeutics, Inc. INDP|Narxning prognoz qilingan daromadga nisbati BiondVax Pharmaceuticals (SCNI)|Forvard narx/daromad multiplikatori CalciMedica CALI|Narxning prognoz qilingan daromadga nisbati Affimed AFMD|ALLK - Forvard narx/daromad multiplikatori|HOOKIPA Pharma, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com